SALSA MLPA Probemix P170 APP detects copy number variations in the APP gene.
Contents: 38 MLPA probes, including 21 probes for APP (covering all exons).
Tissue: human genomic DNA.
Application: research on early-onset Alzheimer's disease (EOAD) and cerebral amyloid angiopathy (CAA).
For research use only (RUO). Not for use in diagnostics.
The SALSA MLPA Probemix P170 APP is a research use only (RUO) assay for the detection of deletions or duplications in the APP gene, which is associated with Early-Onset Alzheimer's Disease (EOAD) and Cerebral Amyloid Angiopathy (CAA).
Duplications in the APP gene result in accumulation of amyloid-β peptides in the parenchymal and vascular deposits and have been implicated in EOAD and CAA. The size of duplications can vary among patients, ranging from 0.58 to 6.37 Mb.
More information is available at https://www.ncbi.nlm.nih.gov/books/NBK1161/.
SALSA MLPA Probemix P170 APP is for research use only (RUO) in all territories.
A general SALSA MLPA Reagent Kit is required for MLPA experiments (to be ordered separately).
The prices above are list prices for direct orders from MRC Holland. Contact us for a quote that takes discounts and additional costs (such as shipping costs) into account. Different prices apply for orders through one of our sales partners; contact your local supplier for a quote.
Inclusion of a positive sample is usually not required, but can be useful for the analysis of your experiments. MRC Holland has very limited access to positive samples and cannot supply such samples. We recommend using positive samples from your own collection. Alternatively, you can use positive samples from an online biorepository, such as the Coriell Institute.
We have no information about specific commercially available positive samples that can be used with this product.